Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer - Contacts and Locations

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

This study has been completed.

Study NCT00072865. Last updated on January 24, 2007. Information provided by Eli Lilly and Company

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072865

Locations


Russian Federation, Russia
	For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
	Moscow, Russia, Russian Federation
	For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
	Saint Petersburg, Russia, Russian Federation

Sponsors and Collaborators

Eli Lilly and Company

Investigators


Study Director:	Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)	Eli Lilly and Company